Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phloroglucinol vs pinaverium for irritable bowel syndrome (non-inferiority, double-blind RCT)
KCT0011532Phase 4Completed
- Sponsor
- Uijeongbu Eulji University Hospital
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of phloroglucinol in irritable bowel syndrome (IBS), sponsored by Uijeongbu Eulji University Hospital. Started Jun 2022; status: completed.
02
Drugs
phloroglucinol
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on KCT0011532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011532.